Janus Henderson Group plc 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:10 pm Sale |
2024-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
JANUS HENDERSON GROUP PLC JHG |
2,208,394 10.100% |
-693,656 (-23.90%) |
Filing |
| 2024-02-13 5:55 pm Sale |
2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
JANUS HENDERSON GROUP PLC JHG |
2,902,050 14.700% |
-140,611 (-4.62%) |
Filing |
| 2023-10-10 1:05 pm Purchase |
2023-09-29 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
JANUS HENDERSON GROUP PLC JHG |
3,042,661 15.400% |
1,132,360 (+59.28%) |
Filing |
| 2023-09-08 4:36 pm Purchase |
2023-08-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
JANUS HENDERSON GROUP PLC JHG |
1,910,301 10.300% |
1,910,301 (New Position) |
Filing |